Therapy delivery system having an open architecture and a method thereof

Therapy delivery system having an open architecture and a method thereof

  • CN 101,743,550 B
  • Filed: 05/15/2008
  • Issued: 12/17/2014
  • Est. Priority Date: 06/27/2007
  • Status: Active Grant
First Claim
Patent Images

1. one kind for the treatment transmission system (10) of individual, comprising:

  • Therapeutic dose module (11), comprise the operation control system (12) with open architecture, it is supported the operation of described treatment transmission system and has the first control algolithm (16) can replaced by the second control algolithm (18) customized for individual human needs, first and second control algolithms (16,

         18) treatment for determining for individual is prescribed, the described open architecture of wherein said operation control system provides the Logic Separation of the first control algolithm and the second control algolithm to make the first control algolithm to remove from described operation control system and can be replaced by the second control algolithm and not disturb the described hardware for the treatment of transmission system or the operation function of software, andThe analog module (36) of test environment is provided, enable test second control algolithm (18) when it is simulated at least one or more physiological condition of individual and was implemented in therapeutic dose module (11) under the test environment before the second control algolithm (18) is used for that in treatment transmission system (10) treatment determined by the second control algolithm (18) is delivered to individual, wherein;

    The test of described second control algolithm in described analog module comprises and totally uses the second control algolithm to the virtual patient of test environment, and make in treatment transmission system for identify before transmitting treatment to individual that the treatment determined by the second control algolithm causes, overall for virtual patient in any harmful result of patient health;

    Wherein said therapeutic dose module comprises fail-safe module, and one or more treatment that described fail-safe Module Specification and the first and second control algolithms have nothing to do limits, and it stops the transmission of the treatment beyond treatment restriction.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×